Public Company News

Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026

Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical  (SHA: 688139) showcased a portfolio of automated and digital solutions sp...

2026-09-01 22:50 3654

Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026

Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical  (SHA: 688139) showcased a portfolio of automated and digital solutions sp...

2026-09-01 22:48 2940

Youlife Signs Strategic Cooperation Agreement to Develop Industry-Education Integration Vocational Education Park in Ji'an

SHANGHAI, Sept. 1, 2026 /PRNewswire/ -- Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that its subsidiary, Jiangxi Youlan Sci-Tech Industry Development Co., Ltd., has entered into a strategic cooperation f...

2026-09-01 20:57 2177

Intercontinental Exchange Adds to Weather Tracking Features: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 1, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-09-01 20:56 4991

REJURAN COSMETICS Expands Across Canada with Nationwide Sephora Launch

Premium derma-cosmetic brand from PharmaResearch, the Korean pharmaceutical company behind the globally recognized REJURAN® skin booster available in more than 50 countries, will launch in Sephora Canada stores. SEOUL, South Korea, Sept. 1, 2026 /PRNewswire/ -- REJURAN COSMETICS, the premium der...

2026-09-01 20:47 3213

Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development

NANJING, China, Sept. 1, 2026 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global licensing agreement with Roche for the development and commercialization of SIM0660, a tri-specific antibody targeting...

2026-09-01 20:28 3644

Global-Leading Robobrain Firm Mech-Mind Robotics Lists on Hong Kong Stock Exchange

SHANGHAI, Sept. 1, 2026 /PRNewswire/ -- Mech-Mind Robotics, a portfolio company of Qiming Venture Partners and a global-leading robobrain company, successfully listed on the Hong Kong Stock Exchange on September 1, 2026 Beijing time and became the first listed embodied intelligence "Eye-Brain-Han...

2026-09-01 20:16 5563

QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery

Joint test on IonQ Forte hardware lands within 4% of benchmark, clearing the chemical-accuracy bar for enzyme active-site modeling via Amazon Braket PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- QC Ware today announced a technology demonstration of a hybrid quantum-classical chemistry workflow...

2026-09-01 20:00 2570

Ribbon Bolsters Its Market-Leading Critical Infrastructure Portfolio

New generation of routers delivers expanded routing, automation, security and synchronization capabilities PLANO, Texas, Sept. 1, 2026 /PRNewswire/ -- Ribbon Communications Inc.

2026-09-01 20:00 2640

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and in Combination with Checkpoint Inhibition Kazia is Preparing to Advance Pa...

2026-09-01 19:30 2379

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer

Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity Three-Arm Expansion of the Ongoing TNBC Trial Will Evaluate Paxalisib Plus Fulvestrant, With Palbociclib, Versus Standard-of-Care First Patient Expec...

2026-09-01 19:15 2620

Xiami Music & Arts Festival Returns for 5th Edition with The Cardigans Leading a Global Lineup

* The festival has presented 33 international acts over the past five years. * It has expanded beyond music to encompass theater, exhibitions, film, designer toys and other forms of entertainment. * This year's festival secured partnerships with 30 brands, continuing the growth of its commer...

2026-09-01 17:36 3306

Xcite Uranium Commences Drilling at the Past-Producing Lorado Uranium Project, Saskatchewan

VANCOUVER, BC, Sept. 1, 2026 /PRNewswire/ -- Xcite Uranium Inc. (CSE: XRI) (" Xcite" or the "Company") is pleased to announce the commencement of the diamond drilling program at theLorado Uranium Project located near Uranium City, Saskatchewan.  The 1200m, 3-hole program will test for uranium min...

2026-09-01 16:00 1751

Zoomlion Strengthens European Localization through Expanded Service, Manufacturing, and Technology Collaboration

CHANGSHA, China, Sept. 1, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion" or "the Company") is strengthening its localized operations in Europe following a partner meeting held on August 19 at Zoomlion's factory in Germany and a visit to its German subsidia...

2026-09-01 15:26 5299

JIANGXI BIO Announced 2026 Interim Results

Overseas Contract Orders Reach Nearly RMB27.4 mn and R&D Translation Gains Momentum, with the AEPC Platform Reshaping the R&D Paradigm for Equine Polyclonal Antibody Interim Results Highlights   Key Financial Indicators * Revenue amounted to RMB83.3 mn; gross profit amounted to RMB60.3 mn, ...

2026-09-01 14:44 6659

Furuno Unveils New SOLION-100 Terminal for Iridium GMDSS

The SOLION-100 combines GMDSS, Ship Security Alert System and Long-Range Identification and Tracking capabilities in a single Iridium Certus 100 terminal for newbuild and retrofit vessels. HAMBURG, Germany, Sept. 1, 2026 /PRNewswire/ -- Iridium Communications Inc.

2026-09-01 13:01 2367

XPENG Announces Vehicle Delivery Results for August 2026

GUANGZHOU, China, Sept. 1, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868), a leading global Physical AI company, today announced its vehicle delivery results for August 2026. XPENG delivered 39,107 vehicles in August 2026, up 4% year-over-year. On August 11...

2026-09-01 12:32 3089

Otis Appoints Sridhar Rajagopal to Lead Southeast Asia Business

* Leading growth and strengthening customer engagement SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Otis  (NYSE: OTIS), the world's leading elevator and escalator manufacturing, installation, service and modernization company,today announced the appointment of Sridhar Rajagopa...

2026-09-01 12:00 2858

UJU HOLDING 2026 Interim Results: Synergistic Development Across the Diversified Business Matrix, the "Reengineering UJU Overseas" Strategy Sets Sail, and AI Drives Comprehensive Business Upgrades

BEIJING and HONG KONG, Sept. 1, 2026 /PRNewswire/ -- UJU HOLDING (hereinafter referred to as the "Company" or the "Group") announced its 2026 interim results. In the first half of 2026, against the backdrop of the digital marketing industry accelerating its shift from traffic expansion to techno...

2026-09-01 10:30 5738

Baidu Announces Dual-Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited

BEIJING, Aug. 31, 2026 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that the Company's voluntary conversion of its secondary listing status to dual-pri...

2026-09-01 08:00 2899
1 ... 50515253545556 ... 1654